IRIS
STEFANI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 64.046
AS - Asia 17.281
EU - Europa 6.962
SA - Sud America 1.297
Continente sconosciuto - Info sul continente non disponibili 1.173
AF - Africa 128
OC - Oceania 19
Totale 90.906
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 63.537
SG - Singapore 13.173
IT - Italia 1.473
CN - Cina 1.382
BR - Brasile 1.067
IE - Irlanda 972
RU - Federazione Russa 947
HK - Hong Kong 845
UA - Ucraina 826
DE - Germania 688
VN - Vietnam 608
FR - Francia 584
BD - Bangladesh 401
GB - Regno Unito 381
SE - Svezia 299
CA - Canada 251
JP - Giappone 230
FI - Finlandia 203
PL - Polonia 171
KR - Corea 151
NL - Olanda 147
IN - India 113
AR - Argentina 81
MX - Messico 79
ID - Indonesia 72
AT - Austria 49
ZA - Sudafrica 45
IQ - Iraq 44
ES - Italia 43
CO - Colombia 42
JM - Giamaica 40
TR - Turchia 39
CR - Costa Rica 32
EC - Ecuador 32
BE - Belgio 28
PK - Pakistan 27
VE - Venezuela 25
UZ - Uzbekistan 24
EU - Europa 23
MY - Malesia 22
NI - Nicaragua 22
CZ - Repubblica Ceca 19
CL - Cile 18
SA - Arabia Saudita 18
AU - Australia 17
MA - Marocco 17
HN - Honduras 15
KG - Kirghizistan 15
PH - Filippine 15
PY - Paraguay 15
CH - Svizzera 14
EG - Egitto 14
AE - Emirati Arabi Uniti 13
IL - Israele 13
KE - Kenya 13
RO - Romania 13
TT - Trinidad e Tobago 13
LT - Lituania 11
AL - Albania 10
RS - Serbia 10
TW - Taiwan 10
BG - Bulgaria 9
EE - Estonia 9
GR - Grecia 9
NP - Nepal 9
TH - Thailandia 9
BO - Bolivia 8
DK - Danimarca 8
PE - Perù 8
SV - El Salvador 8
TN - Tunisia 8
AZ - Azerbaigian 7
GT - Guatemala 7
SK - Slovacchia (Repubblica Slovacca) 7
DO - Repubblica Dominicana 6
GE - Georgia 6
HR - Croazia 6
IR - Iran 6
JO - Giordania 6
PT - Portogallo 6
DZ - Algeria 5
LB - Libano 5
NG - Nigeria 5
BB - Barbados 4
BZ - Belize 4
KZ - Kazakistan 4
PA - Panama 4
PR - Porto Rico 4
AM - Armenia 3
AO - Angola 3
BY - Bielorussia 3
DM - Dominica 3
ET - Etiopia 3
GD - Grenada 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
PS - Palestinian Territory 3
SC - Seychelles 3
SI - Slovenia 3
AW - Aruba 2
Totale 89.713
Salva come PNG Salva come JPEG
Città #
Wilmington 15.479
Houston 14.778
Woodbridge 13.792
Fairfield 2.190
Singapore 2.028
Ashburn 1.906
San Jose 1.441
Ann Arbor 1.097
Seattle 847
Hong Kong 835
Jacksonville 749
Cambridge 743
Chandler 713
Dublin 650
Council Bluffs 562
Beijing 539
Medford 493
Dearborn 409
Santa Clara 387
Rome 352
New York 304
The Dalles 302
Los Angeles 286
Lawrence 229
Tokyo 204
Lauterbourg 187
Buffalo 169
Hanoi 166
Ho Chi Minh City 163
Moscow 138
Milan 120
San Diego 117
São Paulo 117
Kraków 110
Menlo Park 109
Munich 102
Dallas 99
London 91
Denver 85
Atlanta 79
North Bergen 79
Chicago 78
Brooklyn 68
Toronto 68
Helsinki 67
Phoenix 62
Redondo Beach 58
Montreal 48
Mülheim 48
Warsaw 47
Amsterdam 45
Norwalk 44
Orem 44
Nuremberg 43
Shanghai 42
Jakarta 40
Redwood City 39
Zhengzhou 37
Stockholm 35
Chennai 34
Naples 34
Boardman 33
Johannesburg 32
Mexico City 32
Philadelphia 32
Rio de Janeiro 32
Verona 31
Boston 30
Hefei 30
Monte Vista 30
Da Nang 28
Seoul 28
Durham 27
Manchester 27
San José 27
St Louis 27
Belo Horizonte 26
San Francisco 26
Brussels 25
Palo Alto 25
Elk Grove Village 24
Kunming 24
Miami 24
Detroit 23
Salt Lake City 23
Brasília 22
Falls Church 21
Haiphong 21
Mountain View 21
Nanjing 21
Bologna 20
Florence 20
Managua 20
Columbus 19
University Park 19
Kingston 18
Dhaka 17
Frankfurt am Main 17
Poplar 17
Tampa 17
Totale 65.183
Salva come PNG Salva come JPEG
Nome #
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process 649
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. 629
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 628
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease 623
Therapy for dyskinesias in Parkinson’s disease patients 620
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study. 616
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 613
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? 612
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 606
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine 606
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 605
Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson's disease 583
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 580
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 578
Posterior cortical atrophy with unilateral occipito-temporal degeneration 569
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 567
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 561
Motor and non-motor effects of PPN-DBS in PD patients: insights from intra-operative electrophysiology 556
Re: Stereotactic microdialysis of the basal ganglia in Parkinson's disease 554
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 550
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 545
Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease 545
Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. 535
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 530
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 523
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 518
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease 516
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 515
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 512
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 510
Clinical and genetic study of a large SPG4 Italian family 507
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 507
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 505
CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia 504
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease 503
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 500
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration 500
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms 500
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment 497
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 494
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease 490
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature 489
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 487
Selective vulnerability of pallidal neurons in the early phases of manganese intoxication 484
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 484
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 482
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 482
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 480
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 478
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 477
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 474
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 471
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 471
Acute nigro-striatal blockade alters cortico-striatal encoding: An in vivo electrophysiological study 469
CSF biomarker variability in the Alzheimer's Association quality control program 468
The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease 462
Distinct roles of cortical and pallidal β and γ frequencies in hemiparkinsonian and dyskinetic rats 462
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 461
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. 459
Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients 459
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 457
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus 457
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 454
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 451
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 450
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 450
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations 450
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation 449
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 448
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 447
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease 446
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study 444
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 444
Alexithymia is a non-motor symptom of Parkinson disease 443
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 443
Outward potassium currents activated by depolarization in rat globus pallidus 441
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 440
Thalamic ¹²³I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 436
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 436
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms 435
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 433
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 431
Pramipexole in comparison to l-dopa: a neuropsychological study 431
Basic research in substantia nigra and ventral tegmental area: clinical implications 425
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 424
Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: effects on gait in Parkinson's disease 424
Theta Burst Stimulation Modulates Cerebellar-Cortical Connectivity in Patients with Progressive Supranuclear Palsy 424
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG. 422
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 422
Catecholamine-based treatment in AD patients: expectations and delusions 422
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 421
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 417
The modulation of dopamine receptors in rat striatum 416
The modulation of calcium currents by the activation of mGluRs. Functional implications 415
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons 414
Deep brain stimulation in Parkinson's disease patients: biochemical evidence 412
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.(Reply from the authors) 411
Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease" by Lista et al 409
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 407
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms 406
Totale 48.967
Salva come PNG Salva come JPEG
Categoria #
all - tutte 223.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 223.044
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.265 0 0 0 125 87 152 586 143 134 142 229 667
2022/20232.175 271 160 78 217 166 592 240 115 167 6 118 45
2023/2024855 90 33 63 18 85 143 36 144 22 53 14 154
2024/202515.405 171 1.254 584 330 113 471 464 357 642 527 6.024 4.468
2025/202611.194 814 382 1.173 924 887 350 1.325 1.466 1.228 1.181 907 557
2026/20274.620 941 740 2.182 757 0 0 0 0 0 0 0 0
Totale 90.906